Tharimmune, Inc. — Director's Dealing 2024

Aug 12, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tharimmune, Inc. (THAR)
CIK: 0001861657
Period of Report: 2024-08-09

Reporting Person: MILBY RANDY (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-09	Options (right to buy)	$2.9250	A	57707	Acquired	2034-08-09	Common stock (57707)	Direct

Footnotes

F1: On August 9, 2024, the Reporting Person was granted options ("Options") to purchase up to 57,707 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.